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Background: No study has been performed to compare the impacts of migraine and major depressive episode
(MDE) on depression, anxiety and somatic symptoms, and health-related quality of life (HRQoL) among psychiatric
outpatients. The aim of this study was to investigate the above issue.
Methods: This study enrolled consecutive psychiatric outpatients with mood and/or anxiety disorders who
undertook a first visit to a medical center. Migraine was diagnosed according to the International Classification of
Headache Disorders, 2nd edition. Three psychometric scales and the Short-Form 36 were administered. General linear
models were used to estimate the difference in scores contributed by either migraine or MDE. Multiple linear
regressions were employed to compare the variance of these scores explained by migraine or MDE.
Results: Among 214 enrolled participants, 35.0% had migraine. Bipolar II disorder patients (70.0%) had the highest
percentage of migraine, followed by major depressive disorder (49.1%) and only anxiety disorder (24.5%). Patients
with migraine had worse depression, anxiety, and somatic symptoms and lower SF-36 scores than those without.
The estimated differences in the scores of physical functioning, bodily pain, and somatic symptoms contributed by
migraine were not lower than those contributed by MDE. The regression model demonstrated the variance
explained by migraine was significantly greater than that explained by MDE in physical and pain symptoms.
Conclusions: Migraine was common and the impact of migraine on physical and pain symptoms was greater than
MDE among psychiatric outpatients. Integration of treatment strategies for migraine into psychiatric treatment
plans should be considered.
Keywords: Depression, Anxiety, Headache, Pain, Quality of life, SomatizationBackground
Migraine, mood disorders, and anxiety disorders are
comorbid with each other and interact [1-6]. Many stud-
ies have investigated the prevalence and impact of de-
pression and/or anxiety among patients with migraine.
These studies show that comorbidity with depression
and/or anxiety is common and related to a poorer qual-
ity of life, increases the suicide risk, and predicts a
poorer outcome among patients with migraine [7-11].
Many other studies, on the contrary, have investigated
the frequency and impact of migraine among patients
with mood and/or anxiety disorders [12-20]. Most of
these studies evaluated the impact of migraine on* Correspondence: sjwang@vghtpe.gov.tw
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in any medium, provided the original work is ppsychiatric outpatients with depression or major depres-
sive disorder (MDD) [12-16]. Comorbidity with migraine
is associated with more severe depression, anxiety, and
somatic symptoms, as well as a poorer health-related
quality of life (HRQoL) [14-16].
Patients with depression may suffer from impaired
multiple functions and have an increased social burden
[21]. Major depressive episode (MDE) is one of the
worst states of mood disorders and may be most able to
reflect functional impairments of depression. Similarly,
migraine also causes significant functional impairment
in multiple dimensions [22]. To the best of our know-
ledge, no study has been performed to compare the
impacts of migraine and MDE on depression, anxiety
and somatic symptoms as well as HRQoL among psychi-
atric outpatients with mood and anxiety disorders (or
non-psychotic outpatients).Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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atric outpatients with mood and/or anxiety disorder is
important because the information might alert physicians
to note migraine and to integrate the treatment plan for
mood disorders, anxiety, and migraine. Therefore, the
study aimed to compare the differences in depression,
anxiety and somatic symptoms, as well as HRQoL,
associated with the presence of migraine or MDE among
psychiatric outpatients with mood and/or anxiety
disorders. We hypothesized that psychiatric outpatients
with migraine have a greater severity of depression, anx-
iety, and somatic symptoms as well as a poorer HRQoL
based on previous studies [12-16]. Moreover, the impacts
of migraine on physical and pain symptoms might be as
important as those of a current MDE.Methods
Subjects
This study enrolled subjects between September 2007
and August 2009 in the psychiatric outpatient clinic of
Chang Gung Memorial Hospital, a medical center in
northern Taiwan. The study participants were consecu-
tive psychiatric outpatients (20–60-years-old) who
visited our clinic for the first time and had not taken any
medications for psychiatric disorders and migraine pre-
vention within the previous 4 weeks. Four exclusion cri-
teria were established: 1) psychotic disorders, such as
schizophrenia, delusional disorder, and other psychotic
disorders; 2) mental retardation, delirium, dementia, and
mental disorders due to general medical conditions; 3)
psychotic symptoms, catatonic features, severe psycho-
motor retardation, or a current manic episode in the
index month, which may cause difficulty in completing
self-administered scales or cooperating with the study
process; 4) a history of substance dependence or abuse
without full remission in the index month.
The government-run single-payer compulsory Na-
tional Health Insurance program in Taiwan enrolls more
than 96% of Taiwan’s population [23]. The insured in
Taiwan have complete freedom to choose their health
care providers. They can seek care at tertiary care
institutions, regardless of the severity of their illness.
Only 2.3% of patients in the clinics of a university
teaching hospital in Taiwan were referred from primary
clinics [24]. Therefore, although our patients were
collected from a medical center, they did not differ much
in the demographic patterns of those attending primary
psychiatric clinics.
The study was approved by the Institutional Review
Board of Chang Gung Memorial Hospital. A written
informed consent, based on the guidelines regulated in
the Declaration of Helsinki, was obtained from all
subjects prior to study enrollment.Assessment of the severity of depression, anxiety, and
somatic symptoms, and HRQoL
The Hamilton Depression Rating Scale (HAMD), the
Depression and Somatic Symptoms Scale (DSSS), and
the Hospital Anxiety and Depression Scale (HADS) were
used to evaluate depression, anxiety, and somatic
symptoms over the previous week [25-29].
12 items in the Depression Subscale (DS) and 10 items
in the Somatic Subscale (SS), which includes five pain
symptoms and five non-pain somatic symptoms. The re-
liability and validity of the DSSS have been reported in
previous studies [25-27].
The HADS comprises 7 items in the anxiety subscale
(HADS-A) and 7 items in the depression subscale
(HADS-D) and does not include any somatic symptoms
[29]. Therefore, the HADS can measure depression and
anxiety without being confounded by somatic
symptoms.
The three scales were used simultaneously to inves-
tigate the severity of depression, anxiety, and somatic
symptoms. The total scores for each scale or subscale
range from 0 to 36 for the DS and 0 to 30 for the
SS, 0 to 52 for the HAMD, and 0 to 21 for the
HADS-D and HADS-A. A higher score indicates a
greater severity.
The acute version of the Short-Form 36 (SF-36), which
evaluated the HRQoL in the past week with the same
items as the SF-36, was used to be compatible with the
evaluating period of the three psychometric scales. The
SF-36 includes eight domains: physical functioning (PF),
role limitations-physical (RP), bodily pain (BP), general
health perceptions (GH), vitality (VT), social functioning
(SF), role limitations-emotional (RE), and mental health
(MH) [30]. A higher score indicates a better HRQoL.
The scores of each subscale ranged from 0 (lowest well-
being) to 100 (highest well-being). According to the
SF-36 Health Survey Manual, a difference of more than
5 points in each subscale of the SF-36 is considered
clinically significant. The Taiwanese version of the SF-36
shows good validity and reliability [31].
The DSSS, HADS, SF-36 were self-administered scales.
The HAMD was assessed by a psychiatrist, who was
blinded to the results of other psychometric scales, psy-
chiatric diagnoses, and headache diagnoses.
The DSSS is a self-administered scale composed ofDiagnoses of psychiatric disorders
Another psychiatrist, who was blinded to the diagnosis of
headache and the results of these scales, used the
Structured Clinical Interview for DSM-IV-TR to diagnose
mood and anxiety disorders [32]. If patients had mood
and anxiety disorders simultaneously, their diagnoses were
categorized as bipolar disorders or MDD, not anxiety
Table 1 The percentages of headache diagnoses
Headache diagnosis Number Percentage
Chronic migraine a 30 14.0
Episodic migraine b 45 21.0
Probable migraine 29 13.6
Chronic tension-type headache 4 1.9
Episodic tension-type headache 40 18.7
Probable tension-type headache 26 12.1
Other headache 12 5.6
No headache 28 13.1
Total 214 100
a Eight (26.7%) patients also had medication-overuse headache.
b Six (13.3%) of them had migraine with aura.
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lar disorders, MDD, anxiety-only disorders, and others.
Assessment of headache
Headache diagnosis
All patients completed a structured headache intake form,
designed to meet the operational criteria of the Inter-
national Classification of Headache Disorders, 2nd edition
(ICHD-2) [33] including information for the diagnoses of
migraine and other common headaches, such as headache
frequency, intensity, features, aura, locations, duration,
and precipitating factors, as well as the amount and fre-
quency of use of drugs taken for pain. An experienced
headache specialist (neurologist), who was blinded to the
results of the psychiatric diagnoses and psychometric
scales, interviewed all patients after they had completed
the headache intake form and made headache diagnoses
based on the ICHD-2. Patients with chronic migraine
(CM) with or without medication-overuse headache
(MOH) and episodic migraine (EM) (i.e. migraine with or
without aura) were categorized as the migraine group.
In order to understand the synergic effects of a current
MDE and migraine on depression, anxiety, and somatic
symptoms, patients were divided into four groups: a
current MDE with migraine, a current MDE without mi-
graine, migraine without a current MDE, and others
(neither a current MDE nor migraine).
Headache intensity and frequency assessment
Subjects evaluated their average headache intensity dur-
ing the previous week using a visual analog scale, with 0
representing “no headache” and 10 representing “head-
ache as severe as I can imagine.” The total number of
headache days in the past week was also collected.
Statistical methods
We used SPSS for Windows 12.0 to perform the statistical
analyses. In performing independent t-tests, Bonferroni
corrections were used due to multiple comparisons (statis-
tical significance: p < 0.01 for HAMD, DS, SS, HADS-D,
and HADS-A and p < 0.006 for the eight SF-36 subscales).
One-way analysis of variance (ANOVA) with post-hoc
comparisons by Scheffe’s method was used to test the
differences in continuous variables among groups. The
Chi-square and Pearson’s correlation tests were used in
appropriate situations.
To compare the impacts of migraine and MDE, multiple
linear regression analyses with forward selection, which
could prevent multicolinearity, were performed. The
dependent variables were the scores of the depression,
anxiety, and somatic symptoms, as well as the SF-36
subscales. All these dependent variables were continuous
variables. Therefore, using multiple linear regression ana-
lyses was appropriate. The independent variables includedmigraine, a current MDE, and five demographic variables
(age, gender, educational level, marital status, and employ-
ment). Moreover, general linear models were used to
calculate the estimated difference contributed by either
migraine or MDE after controlling for demographic
variables. In statistical analyses, a two-tailed p value < 0.05
was considered statistically significant.
Results
Subjects
During the study period, 231 patients fulfilled the criteria
for enrollment. Of them, 17 patients refused to participate
and 214 (92.6%) subjects completed the study. Table 1
demonstrates that 35.0% of these patients had migraine
and 15.9% had chronic daily headache (CM with or with-
out MOH or chronic tension-type headache).
Table 2 shows the percentages of migraine among psy-
chiatric diagnoses. Patients with bipolar II disorder had
the highest percentage of migraine (70.0%), followed by
MDD (49.1%), only anxiety disorder, and no mood and/
or anxiety disorders. Table 3 shows the demographic
variables and demonstrates that female patients had a
significantly higher percentage of migraine. There was
no significant difference in age, educational years, em-
ployment, and marital status between patients with and
without migraine.
Patients with migraine was associated with a higher risk
of being in a current MDE (69.3% vs. 30.9%, odds ratio
(OR) = 5.05, 95% CI = 2.75–9.28, p < 0.001) compared to
those without migraine. Similarly, patients with migraine
also had a higher risk of a past suicide attempt history
than those without (30.7% vs. 13.7%, OR = 2.79, 95%
CI = 1.40–5.57, p < 0.01).
Comparisons of depression, anxiety, and somatic
severities between patients with and without migraine
Table 3 shows the severities of depression, anxiety, and
somatic symptoms between patients with and without mi-
graine and with and without a current MDE. Compared to
Table 2 The percentage of patients with migraine by
individual psychiatric diagnoses
Number Percentage
Bipolar II disorder 7/10 70.0
Major depressive disorder 54/110 49.1
Only anxiety disorder 12/49 24.5
No above diagnosis 2 /45 4.4
Total 75/214 35.0
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nificantly (p < 0.01) greater severity of depression (HAMD,
HADS-D, DS), anxiety (HADS-A), and somatic symptoms
(SS). Compared to patients without a current MDE,
patients with a current MDE also had a significantly
greater severity of depression, anxiety, and somatic symp-
toms. After controlling for demographic variables by a gen-
eral linear model, the estimated difference in the SS score
contributed by migraine was slightly greater than that
contributed by a current MDE (6.2 vs. 5.3).
Figure 1 shows the scores of depression, anxiety, and
somatic symptoms in four subgroups. There was a trend
that patients with a current MDE and migraine had theTable 3 Comparison of depression, anxiety, and somatic sym
outpatients with and without migraine and MDE
Total (n = 214)
HAMD 18.3 ± 6.3 Migraine (n = 75)
MDE (n = 95)
DS 18.9 ± 8.6 Migraine
MDE
SS 13.0 ± 7.0 Migraine
MDE
HADS-D 10.3 ± 5.0 Migraine
MDE
HADS-A 12.1 ± 4.4 Migraine
MDE
Age (years) 38.3 ± 10.5 Migraine
MDE
Educational years 12.5 ± 2.9 Migraine
MDE
Gender (female, %) 63.1 Migraine
MDE
Employed (yes, %) 66.4 Migraine
MDE
Married (yes, %) 56.5 Migraine
MDE
HAMD Hamilton Depression Rating Scale, DS depression subscale of the Depression
D depression subscale of the Hospital Anxiety and Depression Scale (HADS), HADS-
aEstimated difference contributed by migraine or a MDE after controlling for five degreatest severities of depression, anxiety, and somatic
symptoms, followed by patients with a current MDE
without migraine, patients with migraine without a
current MDE, and patients without a current MDE or
migraine, with the exception of the SS.Comparisons of the SF-36 subscales between patients
with and without migraine
Table 4 shows the differences in the SF-36 subscales
between patients with and without migraine. Patients
with migraine had significantly (p < 0.006) lower scores
(a poorer HRQoL) in the eight subscales as compared
with patients without migraine. Similarly, patients with a
current MDE also had significantly lower scores in all
subscales. After controlling for demographic variables by
a general linear model, the estimated differences be-
tween migraine vs. non-migraine and between a current
MDE vs. no current MDE reached statistical significance
and clinical significance (a difference in score > 5) in all
eight subscales. Of note, the reduction attributed to mi-
graine was slightly greater than that attributed to a
current MDE in the PF (11.2 vs. 9.4) and BP (23.5 vs.
20.0) scores.ptoms as well as demographic variables between
Yes No Estimated difference a
21.6 ± 5.5** 16.5 ± 6.1 4.7**
23.0 ± 4.1** 14.5 ± 5.3 8.1**
24.1 ± 7.9** 16.1 ± 7.6 7.3**
25.3 ± 6.0** 13.8 ± 6.7 10.9**
17.5 ± 6.7** 10.5 ± 5.9 6.2**
16.1 ± 7.1** 10.4 ± 5.9 5.3**
12.8 ± 4.5** 8.9 ± 4.7 3.8**
13.7 ± 3.7** 7.5 ± 4.0 6.1**
13.9 ± 4.0** 11.2 ± 4.4 2.6**
14.4 ± 3.5** 10.3 ± 4.3 4.0**
38.1 ± 9.6 38.5 ± 10.9
36.3 ± 10.0* 40.0 ± 10.6
12.2 ± 2.9 12.7 ± 3.0







and Somatic Symptoms Scale (DSSS), SS somatic subscale of the DSSS, HADS-
A anxiety subscale of the HADS, MDE a current major depressive episode.
mographic variables. * p < 0.05; ** p < 0.01.
Figure 1 The severities of depression, anxiety, and somatic symptoms among patients with different diagnoses or comorbidities.
Group I = a current major depressive episode (MDE) comorbid with migraine; Group II = a current MDE without migraine; Group III = migraine
without a current MDE; Group IV = neither a current MDE nor migraine. HAMD Hamilton Depression Rating Scale, DS depression subscale of the
Depression and Somatic Symptoms Scale (DSSS), SS somatic subscale of the DSSS, HADS-D depression subscale of the Hospital Anxiety and
Depression Scale (HADS), HADS-A anxiety subscale of the HADS. Significance (p < 0.05): Group I vs. II: DS and SS; Group I vs. III: All five subscales;
Group I vs. IV: All five subscales; Group II vs. III: HAMD, DS, and HADS-D; Group II vs. IV: All five subscales except for SS; Group III vs. IV: none.
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anxiety, somatic severity, and the SF-36
Headache intensity was significantly correlated to the
three psychometric scales (the correlation coefficient (r)
ranged from 0.49 SS to 0.29 HADS-D, all p < 0.01)
and the eight SF-36 subscales (r: 0.49 BP to 0.23 SF, all
p < 0.01). The headache frequency was also significantly
correlated to the three psychometric scales (r: 0.54 SS to
0.39 HADS-D, all p < 0.01) and all the SF-36 subscales
(r: 0.47 BP to 0.28 RP, all p < 0.05).The impacts of migraine on depression, anxiety, and
somatic symptoms
Table 5 identifies the factors that independently predict
depression, anxiety, and somatic severities. After control-
ling for demographic variables and a current MDE, mi-
graine was still an independent factor predicting the
severities of depression, anxiety, and somatic symptoms.
The variance of the SS explained by migraine was greater
than that of a current MDE.The impacts of migraine on the SF-36 subscales
After controlling for demographic variables and a
current MDE, migraine was still an independent factor
predicting all the SF-36 subscales, except for VT and
MH (Table 5). The variance in the PF and the BP
explained by migraine was greater than that of a current
MDE.Discussion
Our study showed that the presence of migraine among
psychiatric outpatients was associated with a greater se-
verity of depression, anxiety, and somatic symptoms, and
a poorer HRQoL. Comorbidity with migraine explained a
higher variance on the physical and pain symptoms
compared to a current MDE. Depression and/or anxiety
are often considered important factors related to the se-
verity of somatic or pain symptoms; however, the role of
migraine in somatic and pain symptoms in the psychiatric
field has long been neglected. This study first pointed out
that the importance of migraine was significantly greater
than that of a MDE in predicting pain and somatic
symptoms in the regression models.
Migraine might be a surrogate for somatic and pain
symptoms among these patients. This is imperative be-
cause pain or somatic symptoms are common residual
symptoms, which are related to a poorer prognosis [34],
among depressive patients. It is possible that simultaneous
prevention of migraine during treatment for mood and
anxiety disorders might decrease residual somatic and
pain symptoms and improve the prognosis. Therefore,
physicians should integrate the treatment of migraine into
psychiatric treatment plans. In fact, migraine was com-
mon (35.0%) among these psychiatric outpatients. Patients
with bipolar II disorder had the highest percentage (70%)
of migraine. This result is compatible with Fasmer’s report
(77%) [19]. The percentage of migraine among patients
with MDD was 49.1%, which was close to that reported in
Table 4 Comparison of the Short-Form 36 subscales and headache indices between outpatients with and without
migraine and MDE
Total (n = 214) Yes No Estimated difference a
PF 80.1 ± 20.2 Migraine 71.9 ± 21.8** 84.5 ± 17.9 −11.2**
MDE 74.4 ± 20.9** 84.7 ± 18.5 −9.4**
RP 39.7 ± 40.2 Migraine 23.7 ± 36.0** 48.4 ± 39.7 −23.7**
MDE 24.7 ± 34.9** 51.7 ± 40.2 −28.0**
BP 55.1 ± 27.4 Migraine 38.3 ± 24.4** 64.2 ± 24.7 −23.5**
MDE 43.6 ± 25.6** 64.4 ± 25.4 −20.0**
GH 39.3 ± 21.0 Migraine 31.3 ± 21.5** 43.6 ± 19.5 −11.6**
MDE 29.7 ± 17.4** 46.9 ± 20.6 −15.9**
VT 31.1 ± 22.0 Migraine 21.6 ± 17.1** 36.3 ± 22.7 −13.2**
MDE 17.5 ± 13.5** 42.0 ± 21.5 −23.6**
SF 50.9 ± 27.8 Migraine 39.5 ± 23.7** 57.0 ± 28.0 −18.8**
MDE 36.6 ± 23.2** 62.3 ± 25.9 −25.7**
RE 26.5 ± 37.0 Migraine 11.6 ± 27.7** 34.5 ± 39.0 −22.8**
MDE 6.0 ± 17.5** 42.9 ± 40.3 −35.4**
MH 34.7 ± 20.0 Migraine 26.8 ± 17.1** 39.0 ± 19.8 −10.9**
MDE 22.7 ± 12.0** 44.3 ± 19.4 −20.5**
HI 3.3 ± 3.4 Migraine 6.0 ± 3.3** 1.9 ± 2.5
MDE 4.7 ± 3.4** 2.2 ± 3.0
HF 2.6 ± 2.8 Migraine 4.6 ± 2.6** 1.6 ± 2.2
MDE 3.9 ± 2.8** 1.6 ± 2.2
PF physical functioning, RP role limitations-physical, BP bodily pain, GH general health perceptions, VT vitality, SF social functioning, RE role limitations-emotional,
MH mental health, HI average headache intensity in the past week, HF headache days in the past week, MDE a current major depressive episode.
aEstimated difference contributed by migraine or a MDE after controlling for five demographic variables. ** p < 0.006.
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among patients with only anxiety disorder was 24.5%,
which was lower than that reported in the study of
Senaratne et al. (67%) in an anxiety disorders clinic [17].
This might partially result from our diagnostic algorithm,
i.e., in patients with only anxiety disorder, other psychi-
atric comorbidities, such as MDD and bipolar disorders,
were excluded.
Our results that psychiatric outpatients with migraine
were associated with more somatic or pain symptoms
might be explained by two possible reasons. 1) Imbalance
of neurotransmitters, such as serotonin, noradrenalin, and
dopamine, is responsible for the pathogenesis of migraine
as well as somatic symptoms and depression [35,36].
This is commonly used to explain the close relationship
between migraine, depression, and somatic symptoms;
2) Repeated headache attacks might cause a similar effect
to central sensitization, which is associated with comorbid
pain conditions and a worse headache-related disability
and increases somatic or pain symptoms among psychi-
atric outpatients with migraine [37].
There are several points, which might be helpful for
clinical practice, worth noting. 1) Headache intensity and
frequency were significantly correlated to the severity ofdepression, anxiety, somatic symptoms, and HRQoL.
Therefore, headache intensity and frequency could
be a useful index to predict these mental symptoms
and HRQoL. 2) Depression and migraine independently
predicted negative impacts on quality of life in a general
population [38]. Our results demonstrated that migraine
and a current MDE were independently associated with
depression, anxiety, somatic symptoms, and HRQoL
among these psychiatric outpatients. 3) The study showed
that patients with both a MDE and migraine had the
greatest severity of depression, anxiety, and somatic
symptoms. This demonstrated the synergic effect of de-
pression and migraine. 4) Psychiatric outpatients with mi-
graine had an increased risk of a suicide attempt history.
This result was compatible with previous studies [39]. In
fact, migraine has been neglected in terms of evaluating
suicide risk among psychiatric outpatients.
Our study has the following limitations. 1) Our study
enrolled psychiatric outpatients in a medical center with
several exclusion criteria to prevent confounding effects.
This enrollment process might introduce bias. For ex-
ample, the study excluded patients with a current manic
episode or with psychotic features. Therefore, this study
did not enroll patients with bipolar I disorder. 2) The
Table 5 Independent factors predicting depression,
anxiety, somatic symptoms, and health-related quality of
life among psychiatric outpatients
Independent variable Beta R2 change p value
HAMD MDE 0.58 0.44 < 0.01
Being employed −0.15 0.03 < 0.01
Migraine 0.15 0.02 < 0.01
Age −0.11 0.01 0.03
DS MDE 0.57 0.45 < 0.01
Migraine 0.20 0.04 < 0.01
Age −0.12 0.01 0.01
Gender −0.11 0.01 0.03
SS Migraine 0.32 0.23 < 0.01
MDE 0.27 0.06 < 0.01
Being employed −0.15 0.04 0.01
Gender −0.15 0.02 0.02
HADS-D MDE 0.57 0.39 < 0.01
Migraine 0.16 0.03 0.01
Being employed −0.12 0.01 0.03
HADS-A MDE 0.41 0.21 < 0.01
Being employed −0.13 0.02 0.03
Migraine 0.14 0.02 0.04
PF Migraine −0.22 0.09 < 0.01
MDE −0.17 0.02 0.02
Being employed 0.14 0.02 0.03
RP MDE −0.26 0.11 < 0.01
Migraine −0.20 0.03 < 0.01
BP Migraine −0.35 0.20 < 0.01
MDE −0.25 0.05 < 0.01
Being employed 0.13 0.02 0.03
GH MDE −0.36 0.17 < 0.01
Being employed 0.15 0.03 0.01
Migraine −0.13 0.02 0.045
VT MDE −0.55 0.31 < 0.01
Being employed 0.17 0.03 < 0.01
SF MDE −0.40 0.21 < 0.01
Migraine −0.17 0.02 0.01
Educational years −0.15 0.02 0.01
RE MDE −0.42 0.25 < 0.01
Age 0.15 0.02 0.01
Being employed 0.12 0.02 0.04
Migraine −0.13 0.01 0.04
MH MDE −0.52 0.30 < 0.01
Table 5 Independent factors predicting depression,
anxiety, somatic symptoms, and health-related quality of
life among psychiatric outpatients (Continued)
Being employed 0.16 0.03 < 0.01
Age 0.12 0.01 0.04
HAMD Hamilton Depression Rating Scale, DS depression subscale of the
Depression and Somatic Symptoms Scale (DSSS), SS somatic subscale of the
DSSS, HADS-D depression subscale of the Hospital Anxiety and Depression
Scale (HADS), HADS-A anxiety subscale of the HADS, PF physical functioning,
RP role limitations-physical, BP bodily pain, GH general health perceptions, VT
vitality, SF social functioning, RE role limitations-emotional, MH mental health,
MDE a current major depressive episode.
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was small. The study design, mixing different diagnoses
of mood and anxiety disorders, had the advantage of
reflecting the percentage of migraine among global non-
psychotic outpatients. 3) The headache intensity and
frequency in the past week were recalled by patients.
Collecting data on the two headache parameters prospect-
ively by headache diary might be more reliable. However,
withholding pharmacological treatment while prospect-
ively observing headache parameters might result in eth-
ical problems owing to the suicidal risk. 4) Depression and
migraine are associated with an increased suicide risk. In
the study, only the past history of suicide attempts was
recorded. A comprehensive assessment of suicide risk was
not performed.
Conclusions
In conclusion, migraine was common among psychiatric
outpatients with mood and/or anxiety disorders. Bipolar II
disorder patients had the highest percentage of migraine,
followed by MDD. Patients with migraine had a greater
severity of depression, anxiety, and somatic symptoms, as
well as a poorer HRQoL than those without. Of note, the
association of migraine with PF, BP, and somatic
symptoms might be greater than that of a current MDE.
Because of the high frequency and significant impacts of
migraine on physical and pain symptoms, future studies
should explore how to integrate the treatment strategies
of migraine, mood disorders and anxiety disorders.
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